Pozitronová emisní tomografie (PET) v kombinaci s výpočetní tomografií, popř. s magnetickou rezonancí je zobrazovací vyšetřovací metoda nukleární medicíny. Využívá cíleného funkčního zobrazení specifických vlastností buněk pomocí radiofarmak. Největší uplatnění má PET v s...
The aim of this clinical guideline is to evaluate the benefits and threats/harms of using proton therapy in primary treatment and salvage therapy with respect to survival, disease progression, toxicity and quality of life for the treatment of cancer in pediatric patients compared to other types of radiot...
Lyman, Gary;
Carrier, Marc;
Ay, Cihan;
Nisio, Marcello;
Hicks, Lisa;
Khorana, Alok;
Leavitt, Andrew;
Lee, Agnes;
Macbeth, Fergus;
Morgan, Rebecca;
Noble, Simon;
Sexton, Elizabeth;
Stenehjem, David;
Wiercoioch, Wojtek;
Kahale, Lara;
Alonso-Coello, Pablo.
Venous thromboembolism (VTE) is a common complication among patients with cancer. Patients with cancer and VTE are at a markedly increased risk for morbidity and mortality. These evidence-based guidelines of the American Society of Hematology (ASH) are intended to support patients, clinicians, and other ...
This guideline covers identifying children, young people and adults with symptoms that could be caused by cancer. It outlines appropriate investigations in primary care, and selection of people to refer for a specialist opinion. It aims to help people understand what to expect if they have symptoms that ...
To develop an evidence-based clinical practice guideline for the prevention of oral mucositis in children (0-18 years) receiving treatment for cancer or undergoing haematopoietic stem cell transplantation (HSCT).
The Mucositis Prevention Guideline Development Group was interdisciplinary and included in...
La presente guía aborda el diagnóstico y tratamiento de la ansiedad en pacientes con cáncer y ofrece una serie de recomendaciones dirigidas a disminuir la variabilidad clínica, mejorar la calidad en la atención de la ansiedad en pacientes con cáncer....
We aimed to provide recommendations on the infusion duration of anthracycline chemotherapy agents in children with cancer. This study also serves as a practice example of the essential steps that need to be taken when using a previously published systematic review to develop a high-quality clinical pract...
Objetivo general: Generar recomendaciones basadas en la mejor evidencia disponible acerca de la entrega de cuidados paliativos en niños y adultos con cáncer avanzado...
Arends, J;
Bachmann, P;
Baracos, V;
Barthelemy, N;
Bertz, H;
Bozzetti, F;
Fearon, K;
Hütterer, E;
Isenring, E;
Kaasa, S;
Krznaric, Z;
Laird, B;
Larsson, M;
Laviano, A;
Mühlebach, S;
Muscaritoli, M;
Oldervoll, L;
Ravasco, P;
Solheim, T;
Strasser, F;
de, van, der, Schueren, M;
Preiser, JC.
Cancers are among the leading causes of morbidity and mortality worldwide, and the number of new cases is expected to rise significantly over the next decades. At the same time, all types of cancer treatment, such as surgery, radiation therapy, and pharmacological therapies are improving in sophisticatio...
Dent, S;
Brezden-Masley, C;
Clarke, B;
Davis, MK;
Jassal, DS;
Johnson, C;
Lemieux, J;
Paterson, I;
Sebag, IA;
Simmons, C;
Sulpher, J;
Thain, K;
Thavendiranathan, P;
Wentzell, JR;
Wurtele, N;
Côté, MA;
Fine, NM;
Haddad, H;
Hayley, BD;
Hopkins, S;
Joy, AA;
Rayson, D;
Stadnick, E;
Straatman, L;
Virani, SA.
Modern treatment strategies have led to improvements in cancer survival, however, these gains might be offset by the potential negative effect of cancer therapy on cardiovascular health. Cardiotoxicity is now recognized as a leading cause of long-term morbidity and mortality among cancer survivors. This ...
Antinéoplasiques,
Marqueurs biologiques,
Cardiotoniques,
Cardiotoxines,
Troponine T,
Peptide natriurétique cérébral,
Protéine C-réactive,
Antinéoplasiques/effets indésirables,
Troubles du rythme cardiaque,
Cardiotoxicité,
Thrombose coronarienne,
Diagnostic précoce,
Échocardiographie tridimensionnelle,
Hypertension artérielle/thérapie,
IRM dynamique,
Ischémie myocardique,
Tumeurs/thérapie,
Prévention primaire,
Radiothérapie,
Facteurs de risque,
Dysfonction ventriculaire gauche,
Cardiotoxicité/diagnostic,
Cardiotoxines/effets indésirables,
Radiothérapie/effets indésirables
